Fluticasoni furoas, Umeclidinium, Vilanterolum

Medicinal product name Trelegy Ellipta
Pharmaceutical form Inhalation powder, pre-dispensed
Strength 92 µg/55 µg/22 µg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/17/1236/002 KZSLN30: 1 × 30 Is available
Legal status Rx Prescription (Pr.)
KZSL Next lowest cost medicine
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code R03AL08 Drugs for obstructive airway diseases

Important notice

Additional information regarding the use for persons aged 75+

If used as "DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES"
SubstanceClassComment
Fluticasoni furoasASuitable for older persons. Take into account possible systemic adverse effects. Take interactions into account.
Umeclidinium No data on active substance.
VilanterolumASuitable for older persons. Potentiates sympathomimetic effects. May cause hypokalaemia.

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(715 containers)
Tamro, Berlin-Chemie/Menarini Baltic, Olainfarm, Recipe Plus, Oribalt Rīga, Magnum Medical, Euroaptieka N30: 1 × 30
(1 UD)
Aluminium blister 92.37 
KZSL*
EU/1/17/1236/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/17/1236/002
Date of authorisation Nov 15, 2017
Marketing authorisation holder, country GlaxoSmithKline Trading Services Limited, Ireland